Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing all 2 results
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
v4i3: pp. 85-88 James E Ciecka; Mark L Frigo; Charles H Koretke; Personal Injury and wrongful death| Fringe Benefits 1994
No products in the cart.